Home > Share Market > Stocks > Orchid pharma > Financial Statements> ORCHPHARMA Profit & Loss

Orchid Pharma Ltd Financial Statements

Profit & Loss Statement of Orchid Pharma Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 450 508 683 797
yoy growth (%) (11) (26) (14) (8.80)
Raw materials (229) (243) (350) (393)
As % of sales 50.80 47.90 51.30 49.40
Employee costs (67) (85) (86) (79)
As % of sales 14.90 16.70 12.60 9.97
Other costs (105) (205) (231) (331)
As % of sales 23.30 40.40 33.80 41.60
Operating profit 49.80 (25) 15.70 (7.50)
OPM 11.10 (5) 2.30 (0.90)
Depreciation (109) (126) (133) (141)
Interest expense (51) (4.20) (302) (336)
Other income 15.20 24.50 20.30 27.30
Profit before tax (95) (131) (399) (458)
Taxes -- -- 46.20 48.30
Tax rate -- -- (12) (11)
Minorities and other (21) -- -- --
Adj. profit (117) (131) (353) (409)
Exceptional items -- -- -- (86)
Net profit (117) (131) (353) (495)
yoy growth (%) (11) (63) (29) 77.50
NPM (26) (26) (52) (62)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000